Literature DB >> 9866733

Chlamydia pneumoniae and cardiovascular disease.

L A Campbell1, C C Kuo, J T Grayston.   

Abstract

Chlamydia pneumoniae is a ubiquitous pathogen that causes acute respiratory disease. The spectrum of C. pneumoniae infection has been extended to atherosclerosis and its clinical manifestations. Seroepidemiologic studies have associated C. pneumoniae antibody with coronary artery disease, myocardial infarction, carotid artery disease, and cerebrovascular disease. The association of C. pneumoniae with atherosclerosis is corroborated by the presence of the organism in atherosclerotic lesions throughout the arterial tree and the near absence of the organism in healthy arterial tissue. C. pneumoniae has also been isolated from coronary and carotid atheromatous plaques. To determine whether chronic infection plays a role in initiation or progression of disease, intervention studies in humans have been initiated, and animal models of C. pneumoniae infection have been developed. This review summarizes the evidence for the association and potential role of C. pneumoniae in cardiovascular disease.

Entities:  

Mesh:

Year:  1998        PMID: 9866733      PMCID: PMC2640250          DOI: 10.3201/eid0404.980407

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  19 in total

1.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.

Authors:  G Ong; B J Thomas; A O Mansfield; B R Davidson; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Murine models of Chlamydia pneumoniae infection and atherosclerosis.

Authors:  T C Moazed; C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

Review 5.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.

Authors:  S M Weiss; P M Roblin; C A Gaydos; P Cummings; D L Patton; N Schulhoff; J Shani; R Frankel; K Penney; T C Quinn; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

7.  Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

Authors:  J B Muhlestein; E H Hammond; J F Carlquist; E Radicke; M J Thomson; L A Karagounis; M L Woods; J L Anderson
Journal:  J Am Coll Cardiol       Date:  1996-06       Impact factor: 24.094

8.  Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.

Authors:  R Malinverni; C C Kuo; L A Campbell; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

9.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

10.  Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells.

Authors:  C A Gaydos; J T Summersgill; N N Sahney; J A Ramirez; T C Quinn
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  45 in total

1.  Expression of Chlamydia pneumoniae polymorphic membrane protein family genes.

Authors:  J Grimwood; L Olinger; R S Stephens
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Authors:  K Burian; K Berencsi; V Endresz; Z Gyulai; T Valyi-Nagy; I Valyi-Nagy; M Bakay; Y Geng; D Virok; L Kari; R Hajnal-Papp; G Trinchieri; E Gonczol
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Authors:  Robert E Molestina; Jon B Klein; Richard D Miller; William H Pierce; Julio A Ramirez; James T Summersgill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Evidence that plant-like genes in Chlamydia species reflect an ancestral relationship between Chlamydiaceae, cyanobacteria, and the chloroplast.

Authors:  Fiona S L Brinkman; Jeffrey L Blanchard; Artem Cherkasov; Yossef Av-Gay; Robert C Brunham; Rachel C Fernandez; B Brett Finlay; Sarah P Otto; B F Francis Ouellette; Patrick J Keeling; Ann M Rose; Robert E W Hancock; Steven J M Jones; Hans Greberg
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

6.  Therapeutic Chlamydophila abortus and C. pecorum vaccination transiently reduces bovine mastitis associated with Chlamydophila infection.

Authors:  Carolin Biesenkamp-Uhe; Yihang Li; Hans-Robert Hehnen; Konrad Sachse; Bernhard Kaltenboeck
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

7.  Persons and pathogens: consequences of co-existence.

Authors:  M C Powanda
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

8.  Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae.

Authors:  T D Read; G S A Myers; R C Brunham; W C Nelson; I T Paulsen; J Heidelberg; E Holtzapple; H Khouri; N B Federova; H A Carty; L A Umayam; D H Haft; J Peterson; M J Beanan; O White; S L Salzberg; R-c Hsia; G McClarty; R G Rank; P M Bavoil; C M Fraser
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

9.  Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.

Authors:  Justin F Deniset; Paul K M Cheung; Elena Dibrov; Kaitlin Lee; Sarah Steigerwald; Grant N Pierce
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.